Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Real Estate Showing Signs Of Collateral Damage – Part IV

This final part of our multi-part Real Estate article should help you understand what will likely transpire over the next 6+ months and how the unknown collateral damage may result in a “Double-Dip” price event taking place before August/September 2020....
Chris Vermeulen | May 20, 2020 |

Real Estate Showing Signs Of Collateral Damage

As we continue to digest economic and global data, our researchers have focused on Real Estate as we believe the contraction in the US economy, spanning corporate, main street, and millions of Americans, will quickly reflect in a slowing Real Estate market. Our researcher at...
Chris Vermeulen | May 19, 2020 |

NervGen Pharma: A “Blockbuster Drug” in the Making?

It has the potential to be one of the most disruptive pharmaceutical drug therapies of the modern era, especially for treating Alzheimer’s disease. And that gives it considerable “blockbuster drug” potential – a tantalising opportunity tha...
Marc Davis | June 25, 2021 |

Central Banks Fire Bazooka at Coronavirus. Will Gold Rally?

The new coronavirus has already infected the global economy. The global lockdown means that recession is inevitable. The central banks all over the world have stepped in, including the Fed, cutting interest rates and pumping liquidity into the system. We invite you thus ...
Arkadiusz Sieron | April 20, 2020 |

Cracking the Code to Society’s Most Feared Disease

Even more so than cancer, it’s the one disease that we all fear the most. The thought of falling prey to Alzheimer’s disease and to the inevitable desecration of our mind is something that makes even the bravest among us shudder. ...
Marc Davis | February 7, 2020 |

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma Corp. (TSX-V:NGEN; OTCQX:NGENF) is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast interview about the company’s ongoing Phase 1b/2...
Knox Henderson | February 1, 2024 |

ROCK ready to roll in Saskatchewan

Drills are turning at the Knife Lake Project in Saskatchewan, where Rockridge Resources (TSX-V:ROCK) hopes to meld a resource estimate onto the advanced exploration project rich in volcanogenic massive sulfides (VMS). Knife Lake is currently owned by Eagle Plains Resources...
Richard (Rick) Mills | March 21, 2019 |

TomaGold : A Stock Worth ‘Weighting’ For…

TomaGold Corporation (TSXV: LOT / OTC: TOGOF) is a mineral exploration company that has recently caught my eye. The company is situated quite nicely with some prime real estate. With a head office based in Montreal, it holds interest in five gold properties in Northern Quebec ...
Dr. Kal Kotecha | January 22, 2021 |

Is This A Bear Market When Stocks Crash 20% and Bonds Spike 30%

It is another blood bath in the markets with everything down, including TLT (bonds) and gold. Safe havens falling with stocks is not a good sign as people are not comfortable owning anything, even the safe havens, and this to me is a very bearish sign. Now, with that said...
Chris Vermeulen | March 12, 2020 |

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...
Knox Henderson | March 20, 2024 |
1 2 3 4 5 6 7 8 9 10 ...